04/28/2026 12:42
Vensica Medical Receives FDA IND Clearance to Initiate Phase 2 Study of ViXe, Its Needle-Free Xeomin® Delivery System for Overactive Bladder

Vensica Medical, a clinical-stage company developing needle-free therapeutic delivery solutions for urologic diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of ViXe. The study will evaluate the Vibe® ultrasound-based, needle-free drug delivery system in combination with Xeomin® (incobotulinumtoxinA) for the treatment of overactive bladder (OAB). This press releas...

Communiqués de presse
EQS Group

AFP and Jiji Press Announce Launch of “Fastlook” Japanese News Platform

Agence France-Presse (AFP) and Jiji Press today announced the launch of “Fastlook”, a new platform that will bring AFP’s unparalleled global news coverage to corporate and institutional clients in Japanese. This is the first collaborative service in our more than 75-year history.

Agence France-Presse (AFP) and Jiji Press today announced the launch of “Fastlook”, a new platform that will bring AFP’s unparalleled global news coverage to corporate and institutional clients in Japanese. This is the first collaborative service in our more than 75-year history.
Anglais
05/13/2026 11:30
Vecima, Incognito, and BM COM Announce Turnkey Fiber Broadband Solutions at ANGA COM 2026

Vecima Networks Inc., Incognito Software Systems Inc., and BM COM s.r.o., today announced a strategic collaboration to deliver a fully integrated, turnkey fiber broadband solution, which will be showcased at ANGA COM 2026, May 19–21 in Cologne, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513492655/en/ The joint solution brings together best-in-class fiber access infrastructure, advanced service orchestration, and in-m...

Subscribe to